Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.

scientific article

Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-3223(90)90635-F
P698PubMed publication ID2378921

P50authorOwen M. WolkowitzQ59678011
P2093author name stringThompson K
Weingartner H
Beccaria L
Liddle RA
Gertz B
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectcholecystokininQ60315441
P304page(s)169-173
P577publication date1990-07-01
P1433published inBiological PsychiatryQ4914961
P1476titleHunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.
P478volume28

Reverse relations

cites work (P2860)
Q419033062-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor
Q52915298Adaptation to high-fat diets: effects on eating behaviour and plasma cholecystokinin.
Q47408727Association of cholecystokinin 1 receptor and beta3-adrenergic receptor polymorphisms with midlife weight gain
Q38833748Critical review evaluating the pig as a model for human nutritional physiology
Q34378911Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide
Q73467889Elevated plasma cholecystokinin and appetitive ratings after consumption of a liquid meal in humans
Q41746697Hormonal regulation of appetite and food intake
Q51115263Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonist.
Q28585605Immunoglobulin-like domain containing receptor 1 mediates fat-stimulated cholecystokinin secretion
Q52890694Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
Q43541711Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans
Q41633181Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy.
Q47287867Relationship between hunger-satiety feelings and various metabolic parameters in women with obesity during controlled weight loss
Q35747934Role of gastrointestinal factors in hunger and satiety in man
Q34407562Satiety effects of a physiological dose of cholecystokinin in humans
Q48431716Sulfated cholecystokinin (26-33) induces mild taste aversion conditioning in rats when administered by three different routes
Q33835949The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight
Q34310199The effect of cholecystokinin in controlling appetite and food intake in humans
Q48388438The effects of a peripherally acting cholecystokinin1 receptor antagonist on food intake in rats: implications for the cholecystokinin-satiety hypothesis
Q34621785The gut and food intake: an update for surgeons.
Q42493305The uncovering and characterization of a CCKoma syndrome in enteropancreatic neuroendocrine tumor patients
Q48708390Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion

Search more.